agilon health (NYSE:AGL) PT Raised to $7.00 at Evercore ISI

agilon health (NYSE:AGL) had its price target lifted by Evercore ISI from $5.50 to $7.00 in a research note published on Tuesday, Benzinga reports. The firm currently has an in-line rating on the stock.

Other research analysts have also issued reports about the company. Baird R W upgraded agilon health to a hold rating in a research report on Thursday, May 30th. Citigroup started coverage on agilon health in a research note on Monday, April 22nd. They issued a neutral rating and a $6.00 price objective on the stock. Stifel Nicolaus reduced their price objective on agilon health from $8.00 to $7.00 and set a hold rating on the stock in a research note on Wednesday, May 1st. Robert W. Baird started coverage on agilon health in a research note on Thursday, May 30th. They issued a neutral rating and a $6.00 price objective on the stock. Finally, Truist Financial increased their price objective on agilon health from $6.40 to $6.50 and gave the company a hold rating in a research note on Friday, May 24th. One research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of Hold and an average price target of $9.10.

agilon health Trading Up 2.3 %

AGL opened at $6.29 on Tuesday. agilon health has a 52 week low of $4.41 and a 52 week high of $21.52. The business has a fifty day simple moving average of $6.08 and a 200-day simple moving average of $6.39. The firm has a market cap of $2.59 billion, a P/E ratio of -8.99 and a beta of 0.60. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.04.

agilon health (NYSE:AGL) last released its quarterly earnings results on Tuesday, May 7th. The company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.02) by $0.03. agilon health had a negative return on equity of 26.15% and a negative net margin of 5.67%. The business had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.62 billion. On average, equities analysts expect that agilon health will post -0.34 earnings per share for the current year.

Hedge Funds Weigh In On agilon health

Several hedge funds have recently made changes to their positions in AGL. Capital International Investors grew its holdings in shares of agilon health by 84.7% during the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after purchasing an additional 9,263,296 shares during the last quarter. Capital World Investors grew its holdings in shares of agilon health by 7.4% during the fourth quarter. Capital World Investors now owns 55,218,496 shares of the company’s stock worth $692,992,000 after purchasing an additional 3,813,214 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of agilon health by 46.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 10,139,886 shares of the company’s stock worth $127,256,000 after purchasing an additional 3,195,087 shares during the last quarter. Wellington Management Group LLP grew its holdings in shares of agilon health by 8.3% during the third quarter. Wellington Management Group LLP now owns 41,318,777 shares of the company’s stock worth $733,821,000 after purchasing an additional 3,162,094 shares during the last quarter. Finally, Norges Bank purchased a new position in shares of agilon health during the fourth quarter worth about $27,902,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.